September 16, 2014 10:51 AM ET

Life Sciences Tools and Services

Company Overview of Furiex Pharmaceuticals, Inc.

Executive Profile

Robert P. Ruscher

AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 2 different industries.

54--

Background

Mr. Robert P. Ruscher, Bob served as the President and Chief Executive Officer at Salix Pharmaceuticals Ltd., from 1999 to 2002. Mr. Ruscher also served as an Executive Vice President, Vice President of Business Development, Chief Financial Officer and Corporate Secretary of Salix Pharmaceuticals Ltd. and retired from it in 2005. Before joining Salix in 1995, he practiced law, advising emerging growth pharmaceutical companies in licensing, corporate partnering, financing ...

Corporate Headquarters

3900 Paramount Parkway
Morrisville, North Carolina 27560

United States

Phone: 919-456-7800
Fax: --

Board Members Memberships

1999-2003
Former Director
2010-2013
Former Director, Chairman of Audit Committee, Member of Compensation Committee and Member of Nominating & Governance Committee

Education

BS
University of Virginia
JD
Stanford Graduate School of Business

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$810.2K
Michael W. Bonney B.A.Chief Executive Officer and Director
Cubist Pharmaceuticals Inc.
$750.0K
Gyo Sagara Chief Executive Officer, President and Representative Director
Ono Pharmaceutical Co., Ltd.
--
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$771.2K
Nilesh D. Gupta Managing Director and Executive Director
Lupin Limited
$52.4M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Furiex Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.